The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events
about
Current status of biomarker research in neurologyHomogeneous Biosensing Based on Magnetic Particle LabelsDementia Literacy among Community-Dwelling Older Adults in Urban China: A Cross-sectional Study.Future Therapeutics in Alzheimer's Disease: Development Status of BACE Inhibitors.Evaluating Alzheimer's Disease Progression by Modeling Crosstalk Network DisruptionNo diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and designTau oligomers in cerebrospinal fluid in Alzheimer's disease.Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease.Multiple system atrophy: pathogenic mechanisms and biomarkers.The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease.Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts.Shear-Induced Amyloid Formation in the Brain: II. An Experimental System for Monitoring Amyloid Shear Processes and Investigating Potential Spinal Tap Problems.Shear-Induced Amyloid Formation in the Brain: I. Potential Vascular and Parenchymal ProcessesNew CSF biomarkers on the block.Cerebrospinal fluid in Alzheimer's: A precious tool.Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathiesGut microbiome alterations in Alzheimer's disease.Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease.Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders.Neurogranin as a predictor of memory and executive function decline in MCI patients.Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults.Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease.The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.A Specific Reduction in Aβ1-42 vs. a Universal Loss of Aβ Peptides in CSF Differentiates Alzheimer's Disease From Meningitis and Multiple Sclerosis.The Neurotoxic Role of Extracellular Tau Protein.Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's disease.
P2860
Q26744505-B1E9F7D6-50E6-4B3D-8B95-17BB0E99A432Q26747505-6AEB293F-3568-4540-85D9-7D770319173FQ33770058-50FC3ED5-E7BB-4BA5-B068-E9FCE1A553F1Q35972878-42FFE1C5-732D-4DAD-B035-D7AD105F2F1BQ36477601-DD1E9F3B-3387-45E3-8A59-412FBD728692Q37237233-9C17F389-F1BC-4E8B-80D3-67D0761BEEAAQ37654117-154FA6C5-99E7-4881-BDDB-D1DFCA954F3DQ37733987-FC363DE2-D45D-4FD0-9732-D96021877688Q38781028-B1CA6435-552C-4A06-80FC-0D01499E28E8Q38813304-C18E6E4B-4C2E-4B9A-AC90-423ADBDE943BQ38830945-4C85A27E-CC84-4E06-A478-9F379B657C06Q38873321-6294242C-AC1A-4461-AED5-E72E73499EC5Q39451611-009F34F1-B008-48B0-8F9B-3DB735786730Q41097447-C5C37610-703B-4473-AEE4-8161C608BC78Q41102931-5EFCBE18-E427-43C3-A4A6-B432E3A5CEF9Q41109611-3C54EC6B-57AC-4B01-A138-51C9C74B34AEQ41293029-43988D53-47C0-4ECF-9442-85CF727FB603Q42315799-120E2791-40FA-4BDA-BEBD-4D17893A90B2Q42371467-E29B0499-9881-4C43-B82B-AF92529F0AC7Q42670350-23CB3237-54B7-4301-90D5-39055C81D0AFQ46293399-AB10BEF0-7535-453C-8F9D-60441DC277B4Q47351358-BD783CEB-43D5-4B80-99B2-6EE72281A44DQ47407570-F025DFE6-CE1C-44F7-A912-7DBAC3C0241FQ48425790-902F6B06-C9D3-4EE8-BFF6-B08EEC550FB6Q48504522-D2F828CA-3460-4CFD-85DB-1DBC733243EAQ50048402-7580DB7D-DD6C-4449-9002-3F8643FA4438Q50591921-8A9CC1DE-1240-4A23-9706-0E26EEC5E4EAQ53396870-56CFF947-BD0B-4EC7-A679-A0FCFF635646Q54977832-78610AAC-BBC1-4C96-8364-A8AEBFAACDC8Q55002822-7EE2744E-DEB4-4974-B764-1448A3A54B70Q55080849-0EF286B4-B7C3-42A7-B1DE-26B6FC8C148FQ55283766-8A505423-FDF0-4E48-A9E4-9EF7430BEBDD
P2860
The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The past and the future of Alz ...... e spectrum of molecular events
@ast
The past and the future of Alz ...... e spectrum of molecular events
@en
The past and the future of Alz ...... e spectrum of molecular events
@nl
type
label
The past and the future of Alz ...... e spectrum of molecular events
@ast
The past and the future of Alz ...... e spectrum of molecular events
@en
The past and the future of Alz ...... e spectrum of molecular events
@nl
prefLabel
The past and the future of Alz ...... e spectrum of molecular events
@ast
The past and the future of Alz ...... e spectrum of molecular events
@en
The past and the future of Alz ...... e spectrum of molecular events
@nl
P2860
P921
P3181
P356
P1476
The past and the future of Alz ...... e spectrum of molecular events
@en
P2860
P3181
P356
10.3389/FNINS.2015.00345
P407
P577
2015-01-01T00:00:00Z